Skip to content

Effect of Opuntia Cactus extract in patients with Covid-19

Effect of Opontia Cactus extract on improving pulmonary and clinical function in patients with Covid-19

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200504047298N2
Enrollment
48
Registered
2020-06-15
Start date
2020-07-10
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19.

Interventions

Intervention 1: Intervention group: Cactus Opuntia is purchased from a reputable greenhouse in the form of cactus leaves and is extracted by the extraction machine in 250 cc bottles and is brought to

Sponsors

Karaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients who have CT scan or PCR data in accordance with Covid-19 Patients aged 18 to 60 years Patients who have not hypoxemia (oxygen saturation more than 90%)

Exclusion criteria

Exclusion criteria: Patients who taking herbal supplements are excluded Patients who were receiving mechanical ventilation or extracorporeal membrane oxygenation (ECMO) ? are excluded Patients with signs of multiorgan failure at screening (Exclusion criteria included alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels greater than 5 times the upper limit of the normal range or estimated creatinine clearance of less than 50 ml per minute (by the Cockcroft–Gault formula)) are excluded

Design outcomes

Primary

MeasureTime frame
Improving lung function. Timepoint: Before starting the intervention, Up to 14 days daily after starting the intervention. Method of measurement: Measurement of venous blood Oxygen.

Secondary

MeasureTime frame
Improving clinical performance. Timepoint: Before starting the intervention, Up to 14 days after starting the intervention. Method of measurement: Clinical symptoms include cough, shortness of breath, body aches, headaches, weakness, and body temperature are examined daily.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZeinab Siami

Karaj University of Medical Sciences

z.siami@abzums.ac.ir+98 26 3252 7576

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026